Herold Advisors’s Bausch Health BHC Stock Holding History

Herold Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-300	Closed	-$6.86K	–	238
2022 Q1	$6.86K	Buy	+300	New	+$7.33K	﹤0.01%	643
2021 Q4	–	Sell	-300	Closed	-$8K	–	245
2021 Q3	$8K	Buy	+300	New	+$8.51K	﹤0.01%	613

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Herold Advisors's BHC Position: Q2 2022 in Review

Herold Advisors sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 300 shares — an estimated $6.86K sold.

Herold Advisors first reported a position in BHC in Q3 2021 and held it in 2 quarters. The position peaked at $8K in Q3 2021. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

Herold Advisors reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
Herold Advisors sold 300 Bausch Health shares in Q2 2022, an estimated $6.86K.
Herold Advisors first reported a position in Bausch Health in Q3 2021 and held it in 2 quarters.
Herold Advisors's Bausch Health position peaked at $8K in Q3 2021.
327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Herold Advisors's 13F filing for Q2 2022, filed 15 Jul 2022.